NLRP3 and graft versus host disease: While NLRP3 and IL-1β has been reported to be required for T-cell-(CD4+ and CD8+) mediated GVHD through pathological Th17 induction13, 58, our study showed that NLRP3 inflammasome is also required for CTL-mediated GVHD through promoting CTL functions.